Y1R may be responsible of unfavorable effects in epilepsy, because administration of Y1R antagonists produces antiepileptic effects in animal models (Gariboldi et al., 1998; Vezzani et al., 2000) and Y1 KO mice display reduced mortality rate upon NPY administration (Lin et al., 2006). The gene discussed is NPY; the disease is epilepsy.